Publication Author: Basu_Anirban
-
Estimating the Medical Care Costs of Obesity in the United States: Systematic Review, Meta-Analysis, and Empirical Analysis.
Kim DD, Basu A. Estimating the Medical Care Costs of Obesity in the United States: Systematic Review, Meta-Analysis, and Empirical Analysis. Value Health. 2016 Jul-Aug;19(5):602-13. doi: 10.1016/j.jval.2016.02.008. Epub 2016 Apr 6. Review.
rakerr2
-
In-Hospital Outcomes and Costs Among Patients Hospitalized During a Return Visit to the Emergency Department.
Sabbatini AK, Kocher KE, Basu A, Hsia RY. In-Hospital Outcomes and Costs Among Patients Hospitalized During a Return Visit to the Emergency Department. JAMA. 2016 Feb 16;315(7):663-71. doi: 10.1001/jama.2016.0649.
rakerr2
-
Predicting Low Accrual in the National Cancer Institute’s Cooperative Group Clinical Trials.
Bennette CS, Ramsey SD, McDermott CL, Carlson JJ, Basu A, Veenstra DL. Predicting Low Accrual in the National Cancer Institute’s Cooperative Group Clinical Trials. J Natl Cancer Inst. 2015 Dec 29;108(2). pii: djv324. doi: 10.1093/jnci/djv324. Print 2016 F
rakerr2
-
Workplace Stress and Working from Home Influence Depressive Symptoms Among Employed Women with Young Children.
Shepherd-Banigan M, Bell JF, Basu A, Booth-LaForce C, Harris JR. Workplace Stress and Working from Home Influence Depressive Symptoms Among Employed Women with Young Children. Int J Behav Med. 2016 Feb;23(1):102-11. doi: 10.1007/s12529-015-9482-2.
rakerr2
-
Long-term costs of introducing HPV-DNA post-treatment surveillance to national cervical cancer screening in Ireland.
Agapova M, Duignan A, Smith A, O’Neill C, Basu A. Long-term costs of introducing HPV-DNA post-treatment surveillance to national cervical cancer screening in Ireland. Expert Rev Pharmacoecon Outcomes Res. 2015 Dec;15(6):999-1005. doi: 10.1586/14737167.201
rakerr2
-
Welfare implications of learning through solicitation versus diversification in health care.
Basu A. Welfare implications of learning through solicitation versus diversification in health care. J Health Econ. 2015 Jul;42:165-73. doi: 10.1016/j.jhealeco.2015.04.001. Epub 2015 Apr 20.
rakerr2
-
Financing cures in the United States.
Basu A. Financing cures in the United States. Expert Rev Pharmacoecon Outcomes Res. 2015 Feb;15(1):1-4. doi: 10.1586/14737167.2015.990887. Epub 2014 Dec 6.
rakerr2
-
Are Elderly Patients With Clinically Localized Prostate Cancer Overtreated? Exploring Heterogeneity in Survival Effects.
Basu A, Gore JL. Are Elderly Patients With Clinically Localized Prostate Cancer Overtreated? Exploring Heterogeneity in Survival Effects. Med Care. 2015 Jan;53(1):79-86.
rakerr2
-
ESTIMATING PERSON-CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS.
Basu A. ESTIMATING PERSON-CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS. J Appl Econ (Chichester Engl). 2014 June/July;29(4):671-691.
rakerr2
-
Can we make smart choices between OLS and contaminated IV methods?
Basu A, Chan KC. Can we make smart choices between ols and contaminated iv methods? Health Econ. 2014 Apr;23(4):462-72. doi: 10.1002/hec.2926. Epub 2013 Jun 13.
rakerr2